chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Myalgia
Clinical narrative: chest was killing me, from the upper half to my neck; chest was killing me, from the upper half to my neck; A spontaneous report was received from a (Reporter Consumer) concerning a  female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events (PT term) list  is  1.chest discomfort 2.Myalgia  The patient's medical history was not provided. No relevant concomitant medications were reported.   On Date of  23-jan-2021, the patient received  first of two planned doses of mRNA-1273 (lot/batch: is  unknown) intramuscularly in the Anatomical location for prophylaxis of COVID-19 infection. On date of 24-jan-2021 The patient experienced the events list (verbatims)  Her chest discomfort whole day from upper half of neck. and myalgia.    No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.  The events, chest discomfort from upper half of neck and Myalgia were considered  NOT RESLOVED on 24-jan-2021; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Heavy diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Heavy diarrhea) in a 95-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE, ATORVASTATIN CALCIUM (LIPITOR), APIXABAN and LOPERAMIDE HYDROCHLORIDE (IMODIUM) for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced DIARRHOEA (Heavy diarrhea). At the time of the report, DIARRHOEA (Heavy diarrhea) was resolving.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash erythematous
Clinical narrative: Arm swelling; Arm is red and itchy; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Arm swelling) and RASH ERYTHEMATOUS (Arm is red and itchy) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced PERIPHERAL SWELLING (Arm swelling) and RASH ERYTHEMATOUS (Arm is red and itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Arm swelling) outcome was unknown and RASH ERYTHEMATOUS (Arm is red and itchy) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypersensitivity, Malaise, Pyrexia
Clinical narrative: very bad reaction; felt like Covid all over again; headache; fever; was in bed for days, more tired than normal; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (very bad reaction), PYREXIA (fever), HEADACHE (headache), MALAISE (felt like Covid all over again) and FATIGUE (was in bed for days, more tired than normal) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in March 2020. Concomitant products included OMEPRAZOLE and PAROXETINE for an unknown indication, HMG COA REDUCTASE INHIBITORS.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced HYPERSENSITIVITY (very bad reaction), PYREXIA (fever), HEADACHE (headache), MALAISE (felt like Covid all over again) and FATIGUE (was in bed for days, more tired than normal). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (very bad reaction), PYREXIA (fever), HEADACHE (headache), MALAISE (felt like Covid all over again) and FATIGUE (was in bed for days, more tired than normal) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other medications also include vitamins and something for stomach.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: brushy, itchy arm; hot to touch; Red arm 10 days after receiving the Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (brushy, itchy arm), INJECTION SITE WARMTH (hot to touch) and INJECTION SITE ERYTHEMA (Red arm 10 days after receiving the Moderna COVID-19 vaccine) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 28-Jan-2021, the patient experienced INJECTION SITE PRURITUS (brushy, itchy arm), INJECTION SITE WARMTH (hot to touch) and INJECTION SITE ERYTHEMA (Red arm 10 days after receiving the Moderna COVID-19 vaccine).   At the time of the report, INJECTION SITE PRURITUS (brushy, itchy arm), INJECTION SITE WARMTH (hot to touch) and INJECTION SITE ERYTHEMA (Red arm 10 days after receiving the Moderna COVID-19 vaccine) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Paraesthesia, Pruritus
Clinical narrative: Tingling/Itchy Sensation - Right Leg; Tingling/Itchy Sensation - Right Leg; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling/Itchy Sensation - Right Leg), PRURITUS (Tingling/Itchy Sensation - Right Leg), HEADACHE (Headache) and FATIGUE (Fatigue) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 15-Jan-2021, the patient experienced PARAESTHESIA (Tingling/Itchy Sensation - Right Leg), PRURITUS (Tingling/Itchy Sensation - Right Leg), HEADACHE (Headache) and FATIGUE (Fatigue). The patient was treated with Human Tranquilizer (BENZODIAZEPINE RELATED DRUGS) for Self-medication, at an unspecified dose and frequency.   On 17-Jan-2021, PARAESTHESIA (Tingling/Itchy Sensation - Right Leg), PRURITUS (Tingling/Itchy Sensation - Right Leg), HEADACHE (Headache) and FATIGUE (Fatigue) had resolved.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Pruritus, Vaccination site mass
Clinical narrative: chills./She lie dawn for 6 hours wrap in blanket; redness; itching allover body including scalp; bumps under skin; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills./She lie dawn for 6 hours wrap in blanket), ERYTHEMA (redness), PRURITUS (itching allover body including scalp) and VACCINATION SITE MASS (bumps under skin) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Allergy to antibiotic (It is reported that patient cannot take Antibiotics, as allergic to it.).   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 10-Feb-2021, the patient experienced CHILLS (chills./She lie dawn for 6 hours wrap in blanket), ERYTHEMA (redness), PRURITUS (itching allover body including scalp) and VACCINATION SITE MASS (bumps under skin).   At the time of the report, CHILLS (chills./She lie dawn for 6 hours wrap in blanket), ERYTHEMA (redness), PRURITUS (itching allover body including scalp) and VACCINATION SITE MASS (bumps under skin) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: redness at injection site (ten days since she got injection); swelling (ten days since she got injection); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness at injection site (ten days since she got injection)) and VACCINATION SITE SWELLING (swelling (ten days since she got injection)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.   On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness at injection site (ten days since she got injection)) and VACCINATION SITE SWELLING (swelling (ten days since she got injection)).   At the time of the report, VACCINATION SITE ERYTHEMA (redness at injection site (ten days since she got injection)) and VACCINATION SITE SWELLING (swelling (ten days since she got injection)) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Otorrhoea
Clinical narrative: It feels like my left ear is draining; This spontaneous case was reported by a consumer and describes the occurrence of OTORRHOEA (It feels like my left ear is draining) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included Bell's palsy in 2017 and Pregnant in 2017.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced OTORRHOEA (It feels like my left ear is draining). At the time of the report, OTORRHOEA (It feels like my left ear is draining) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Pain in extremity, Rash macular, Tenderness
Clinical narrative: Arm is blotchy; Arim is warm to touch; Arm is red; Underarm is tender; Had chills / chills on and off in 2 week period; Arm shoulder to elbow was sore and achy / sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm shoulder to elbow was sore and achy / sore), RASH MACULAR (Arm is blotchy), VACCINATION SITE WARMTH (Arim is warm to touch), ERYTHEMA (Arm is red) and TENDERNESS (Underarm is tender) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported. Concurrent medical conditions included COPD.  On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm shoulder to elbow was sore and achy / sore) and CHILLS (Had chills / chills on and off in 2 week period).   On 15-Feb-2021, the patient experienced RASH MACULAR (Arm is blotchy), VACCINATION SITE WARMTH (Arim is warm to touch), ERYTHEMA (Arm is red) and TENDERNESS (Underarm is tender). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date for Pain, at a dose of UNK UNK.   At the time of the report, PAIN IN EXTREMITY (Arm shoulder to elbow was sore and achy / sore), RASH MACULAR (Arm is blotchy), VACCINATION SITE WARMTH (Arim is warm to touch), ERYTHEMA (Arm is red), TENDERNESS (Underarm is tender) and CHILLS (Had chills / chills on and off in 2 week period) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Arm is blotchy; Arim is warm to touch; Arm is red; Underarm is tender; Had chills / chills on and off in 2 week period; Arm shoulder to elbow was sore and achy / sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm shoulder to elbow was sore and achy / sore), RASH MACULAR (Arm is blotchy), VACCINATION SITE WARMTH (Arim is warm to touch), ERYTHEMA (Arm is red) and TENDERNESS (Underarm is tender) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported. Concurrent medical conditions included COPD.  On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm shoulder to elbow was sore and achy / sore) and CHILLS (Had chills / chills on and off in 2 week period).   On 15-Feb-2021, the patient experienced RASH MACULAR (Arm is blotchy), VACCINATION SITE WARMTH (Arim is warm to touch), ERYTHEMA (Arm is red) and TENDERNESS (Underarm is tender). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date for Pain, at a dose of UNK UNK.   At the time of the report, PAIN IN EXTREMITY (Arm shoulder to elbow was sore and achy / sore), RASH MACULAR (Arm is blotchy), VACCINATION SITE WARMTH (Arim is warm to touch), ERYTHEMA (Arm is red), TENDERNESS (Underarm is tender) and CHILLS (Had chills / chills on and off in 2 week period) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypertension, Pallor, Rash
Clinical narrative: High increase in Blood Pressure; Pale; Rash; Severe Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High increase in Blood Pressure), PALLOR (Pale), RASH (Rash) and HEADACHE (Severe Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (High increase in Blood Pressure), PALLOR (Pale), RASH (Rash) and HEADACHE (Severe Headache). The patient was treated with SODIUM LACTATE (INTRAVENOUS SODIUM LACTATE) at an unspecified dose and frequency. At the time of the report, HYPERTENSION (High increase in Blood Pressure), PALLOR (Pale), RASH (Rash) and HEADACHE (Severe Headache) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itchy sensation near the injection site; swelling area was larger; Arm soreness; redness near the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy sensation near the injection site), VACCINATION SITE PAIN (Arm soreness), VACCINATION SITE ERYTHEMA (redness near the injection site) and VACCINATION SITE SWELLING (swelling area was larger) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm soreness) and VACCINATION SITE ERYTHEMA (redness near the injection site).   On 23-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchy sensation near the injection site) and VACCINATION SITE SWELLING (swelling area was larger).   At the time of the report, VACCINATION SITE PRURITUS (itchy sensation near the injection site), VACCINATION SITE PAIN (Arm soreness), VACCINATION SITE ERYTHEMA (redness near the injection site) and VACCINATION SITE SWELLING (swelling area was larger) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Vaccination site rash
Clinical narrative: Rash at site of injection; Redness at site of injection; itching at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at site of injection), INJECTION SITE ERYTHEMA (Redness at site of injection) and INJECTION SITE PRURITUS (itching at site of injection) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013120A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 21-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash at site of injection), INJECTION SITE ERYTHEMA (Redness at site of injection) and INJECTION SITE PRURITUS (itching at site of injection). The patient was treated with CORTISONE ongoing since an unknown date for Skin reaction, at an unspecified dose and frequency.   At the time of the report, VACCINATION SITE RASH (Rash at site of injection), INJECTION SITE ERYTHEMA (Redness at site of injection) and INJECTION SITE PRURITUS (itching at site of injection) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: redness at the injection site; warm to touch at the injection site; itching at the injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE WARMTH (warm to touch at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE WARMTH (warm to touch at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE WARMTH (warm to touch at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: Knot in right arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Knot in right arm at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE MASS (Knot in right arm at injection site). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency.   At the time of the report, VACCINATION SITE MASS (Knot in right arm at injection site) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Migraine
Clinical narrative: Migraine headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine headache) and CHILLS (Chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol. Concomitant products included ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) and ATORVASTATIN for an unknown indication.    On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced MIGRAINE (Migraine headache) and CHILLS (Chills). At the time of the report, MIGRAINE (Migraine headache) and CHILLS (Chills) outcome was unknown.        No treatment information was provided.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance
Clinical narrative: He is dragging his foot. It seems like he can't walk properly; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (He is dragging his foot. It seems like he can't walk properly) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seizure (is on bunch of seizure medicines) and Disability (adult son who is non-verbal and has special needs.).    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced GAIT DISTURBANCE (He is dragging his foot. It seems like he can't walk properly). At the time of the report, GAIT DISTURBANCE (He is dragging his foot. It seems like he can't walk properly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include a bunch of seizure medicines. No treatment medications were reported.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Sex: M
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Slight Fever; Body aches; Lymph node on clavicle on the side where i got my injection is tender; Lymph node swollen feels like there is a rock above my clavicle; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (Slight Fever), PAIN (Body aches), LYMPH NODE PAIN (Lymph node on clavicle on the side where i got my injection is tender) and LYMPHADENOPATHY (Lymph node swollen feels like there is a rock above my clavicle) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).   On 19-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Slight Fever), PAIN (Body aches), LYMPH NODE PAIN (Lymph node on clavicle on the side where i got my injection is tender) and LYMPHADENOPATHY (Lymph node swollen feels like there is a rock above my clavicle). At the time of the report, PYREXIA (Slight Fever), PAIN (Body aches), LYMPH NODE PAIN (Lymph node on clavicle on the side where i got my injection is tender) and LYMPHADENOPATHY (Lymph node swollen feels like there is a rock above my clavicle) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reporter.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Feeling tired) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced FATIGUE (Feeling tired). At the time of the report, FATIGUE (Feeling tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Headache
Clinical narrative: It looks like he is suffering from a headache. He holds his head a lot; he is in general discomfort; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (It looks like he is suffering from a headache. He holds his head a lot) and DISCOMFORT (he is in general discomfort) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Brain damage.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced HEADACHE (It looks like he is suffering from a headache. He holds his head a lot) and DISCOMFORT (he is in general discomfort). At the time of the report, HEADACHE (It looks like he is suffering from a headache. He holds his head a lot) and DISCOMFORT (he is in general discomfort) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication included Tylenol. No concomitant medications were provided by reporter.   Reporter did not allow further contact
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Erythema, Peripheral swelling, Skin warm, Urticaria
Clinical narrative: Arm was red again; arm was hot as fire and incredibly itchy; arm was hot as fire and incredibly itchy; Redness; Bruise at injection site; Swelling (arm); This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (Redness), CONTUSION (Bruise at injection site), PERIPHERAL SWELLING (Swelling (arm)), VACCINATION SITE ERYTHEMA (Arm was red again) and SKIN WARM (arm was hot as fire and incredibly itchy) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced ERYTHEMA (Redness), CONTUSION (Bruise at injection site) and PERIPHERAL SWELLING (Swelling (arm)). On 24-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Arm was red again), SKIN WARM (arm was hot as fire and incredibly itchy) and URTICARIA (arm was hot as fire and incredibly itchy). On 20-Jan-2021, ERYTHEMA (Redness) had not resolved, PERIPHERAL SWELLING (Swelling (arm)) had resolved. At the time of the report, CONTUSION (Bruise at injection site), VACCINATION SITE ERYTHEMA (Arm was red again), SKIN WARM (arm was hot as fire and incredibly itchy) and URTICARIA (arm was hot as fire and incredibly itchy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication included Benadryl. No concomitant medication were provided by reporter.   Reporter did not allow further contact
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Arm was red again; arm was hot as fire and incredibly itchy; arm was hot as fire and incredibly itchy; Redness; Bruise at injection site; Swelling (arm); This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (Redness), CONTUSION (Bruise at injection site), PERIPHERAL SWELLING (Swelling (arm)), VACCINATION SITE ERYTHEMA (Arm was red again) and SKIN WARM (arm was hot as fire and incredibly itchy) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced ERYTHEMA (Redness), CONTUSION (Bruise at injection site) and PERIPHERAL SWELLING (Swelling (arm)). On 24-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Arm was red again), SKIN WARM (arm was hot as fire and incredibly itchy) and URTICARIA (arm was hot as fire and incredibly itchy). On 20-Jan-2021, ERYTHEMA (Redness) had not resolved, PERIPHERAL SWELLING (Swelling (arm)) had resolved. At the time of the report, CONTUSION (Bruise at injection site), VACCINATION SITE ERYTHEMA (Arm was red again), SKIN WARM (arm was hot as fire and incredibly itchy) and URTICARIA (arm was hot as fire and incredibly itchy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication included Benadryl. No concomitant medication were provided by reporter.   Reporter did not allow further contact
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypersensitivity, Pyrexia, Rash
Clinical narrative: slight fever; headache; slight rash; allergies; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (slight fever), HEADACHE (headache), RASH (slight rash) and HYPERSENSITIVITY (allergies) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and TRAZODONE HYDROCHLORIDE (OLEPTRO) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (slight fever), HEADACHE (headache), RASH (slight rash) and HYPERSENSITIVITY (allergies). At the time of the report, PYREXIA (slight fever), HEADACHE (headache), RASH (slight rash) and HYPERSENSITIVITY (allergies) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided by reporter.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Discomfort on the arm; Redness came back; Swelling came back; Soreness in the arm; A spontaneous report was received on 25 -Jan-2021 from a consumer concerning a 72 years old male patient who received Moderna's COVID-19(mRNA-1273) vaccine and experienced soreness in the arm, redness came back, swelling came back, discomfort on the arm, red line from injection area to 5/6 inches above.  The patient medical history includes allergies: aspirin and penicillin.   Concomitant medications includes pravastatin, allopurinol  On 13-Jan-2021, prior one week to the onset of events, patient received his mRNA-1273(Batch:041N20A) intramuscularly for the prophylaxis of covid-19 infection.  On 13-Jan-2021, patient experienced Soreness in the arm and 9 days later redness came back, Swelling came back. on 25-Jan-2021 discomfort on the arm, red line from injection area to 5/6 inches above.  No laboratory information was provided. Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events were recovered/resolved.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Sorearm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sorearm) and FATIGUE (Fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sorearm) and FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Sorearm) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications included Tylenol. No concomitant medications were provided by reporter.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: swollen 3 inch under injection site; vaccination site itch; vaccination site warmth; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (vaccination site itch), VACCINATION SITE WARMTH (vaccination site warmth) and VACCINATION SITE SWELLING (swollen 3 inch under injection site) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included LINACLOTIDE, ATORVASTATIN, ESTRADIOL, CALCIUM, FAMOTIDINE, OMEPRAZOLE and GABAPENTIN for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (vaccination site itch) and VACCINATION SITE WARMTH (vaccination site warmth). On 15-Jan-2021, the patient experienced VACCINATION SITE SWELLING (swollen 3 inch under injection site). On 18-Jan-2021, VACCINATION SITE PRURITUS (vaccination site itch), VACCINATION SITE WARMTH (vaccination site warmth) and VACCINATION SITE SWELLING (swollen 3 inch under injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included Benadryl and antibiotics.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Arm swollen; Arm hot to touch in area where vaccine was implemented; Arm red in area where vaccine was implemented; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Arm swollen), VACCINATION SITE WARMTH (Arm hot to touch in area where vaccine was implemented) and VACCINATION SITE ERYTHEMA (Arm red in area where vaccine was implemented) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Arm swollen), VACCINATION SITE WARMTH (Arm hot to touch in area where vaccine was implemented) and VACCINATION SITE ERYTHEMA (Arm red in area where vaccine was implemented). At the time of the report, VACCINATION SITE SWELLING (Arm swollen), VACCINATION SITE WARMTH (Arm hot to touch in area where vaccine was implemented) and VACCINATION SITE ERYTHEMA (Arm red in area where vaccine was implemented) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough
Clinical narrative: Tested positive for COVID19; just a little cough; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Tested positive for COVID19) and COUGH (just a little cough) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history.).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced COVID-19 (Tested positive for COVID19) and COUGH (just a little cough). At the time of the report, COVID-19 (Tested positive for COVID19) and COUGH (just a little cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication included Mucinex. No concomitant medications were provided by reporter.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dysgeusia, Fatigue, Insomnia, SARS-CoV-2 test
Clinical narrative: difficulty sleeping; In bed all last week; Joint ache; Metallic taste; A spontaneous report was received from a consumer concerning a 48-years-old, female patient who experienced difficulty sleeping, in bed all last week, joint aches and metallic taste.    The patient's medical history was not provided. Concomitant product use was not provided by the reporter.    On 05 Jan 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 [Lot number 011L20A] intramuscularly in the left hip for prophylaxis of COVID-19 infection.   On unknown date, the patient was in bed for a week. She experienced joint aches. On 16 Jan 2021, she reported having a metallic taste. Treatment information was not provided.    Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events difficulty sleeping, in bed all last week, joint aches and metallic taste were unknown.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm pain( lastweek with moderna vaccine i had some arm pain that not radiate); A spontaneous report was received from a consumer concerning a unknow years old,  patient who developed/experienced arm pain (pain in extremities).  The patient's medical history included cervical neck issue with headache.Concomitant product use was not provided by the reporter. Concomitant product use was not provided by the reporter.   On ?? Dec 2020, the patient received their first of two planned doses of mRNA-1273 batch number not provided intramuscularly for prophylaxis of COVID-19 infection.   On ?? Dec 2020, the patient experienced arm pain.   Treatment information was not provided.    Action taken with mRNA-1273 in response to the event was not provided.  The event lymphadenopathy was considered not recovered.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Blepharospasm, Chills, Palpitations, Presyncope, Pyrexia
Clinical narrative: felt feverish; spot where I got the injection swelled up; got itchy; spot where she got the injection got red; twitch in my right eye; you know the stars that you get when you're in the water too long - I saw stars but I did not pass; heart would go really really fast; chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), VACCINATION SITE SWELLING (spot where I got the injection swelled up), VACCINATION SITE PRURITUS (got itchy), VACCINATION SITE ERYTHEMA (spot where she got the injection got red) and PYREXIA (felt feverish) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced CHILLS (chills), PRESYNCOPE (you know the stars that you get when you're in the water too long - I saw stars but I did not pass) and PALPITATIONS (heart would go really really fast). On 08-Jan-2021, the patient experienced BLEPHAROSPASM (twitch in my right eye). On 13-Jan-2021, the patient experienced VACCINATION SITE SWELLING (spot where I got the injection swelled up), VACCINATION SITE PRURITUS (got itchy) and VACCINATION SITE ERYTHEMA (spot where she got the injection got red). On an unknown date, the patient experienced PYREXIA (felt feverish). On 05-Jan-2021, PRESYNCOPE (you know the stars that you get when you're in the water too long - I saw stars but I did not pass) had resolved. On 07-Jan-2021, CHILLS (chills) had resolved. On 11-Jan-2021, PALPITATIONS (heart would go really really fast) had resolved. On 15-Jan-2021, VACCINATION SITE SWELLING (spot where I got the injection swelled up) had resolved. On 16-Jan-2021, VACCINATION SITE ERYTHEMA (spot where she got the injection got red) had resolved. At the time of the report, VACCINATION SITE PRURITUS (got itchy) had not resolved and PYREXIA (felt feverish) and BLEPHAROSPASM (twitch in my right eye) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: felt feverish; spot where I got the injection swelled up; got itchy; spot where she got the injection got red; twitch in my right eye; you know the stars that you get when you're in the water too long - I saw stars but I did not pass; heart would go really really fast; chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), VACCINATION SITE SWELLING (spot where I got the injection swelled up), VACCINATION SITE PRURITUS (got itchy), VACCINATION SITE ERYTHEMA (spot where she got the injection got red) and PYREXIA (felt feverish) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced CHILLS (chills), PRESYNCOPE (you know the stars that you get when you're in the water too long - I saw stars but I did not pass) and PALPITATIONS (heart would go really really fast). On 08-Jan-2021, the patient experienced BLEPHAROSPASM (twitch in my right eye). On 13-Jan-2021, the patient experienced VACCINATION SITE SWELLING (spot where I got the injection swelled up), VACCINATION SITE PRURITUS (got itchy) and VACCINATION SITE ERYTHEMA (spot where she got the injection got red). On an unknown date, the patient experienced PYREXIA (felt feverish). On 05-Jan-2021, PRESYNCOPE (you know the stars that you get when you're in the water too long - I saw stars but I did not pass) had resolved. On 07-Jan-2021, CHILLS (chills) had resolved. On 11-Jan-2021, PALPITATIONS (heart would go really really fast) had resolved. On 15-Jan-2021, VACCINATION SITE SWELLING (spot where I got the injection swelled up) had resolved. On 16-Jan-2021, VACCINATION SITE ERYTHEMA (spot where she got the injection got red) had resolved. At the time of the report, VACCINATION SITE PRURITUS (got itchy) had not resolved and PYREXIA (felt feverish) and BLEPHAROSPASM (twitch in my right eye) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Fatigue, Feeding disorder
Clinical narrative: Toothache; Aches and pains; Could not eat; Arm pain; lost of strenght, could not held a glass of water; Really really high fever; Nausea; Joint pain; Muscle pain; Fatigue; chils; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), PYREXIA (Really really high fever), PAIN (Aches and pains), NAUSEA (Nausea) and FEEDING DISORDER (Could not eat) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), PYREXIA (Really really high fever), PAIN (Aches and pains), NAUSEA (Nausea), FEEDING DISORDER (Could not eat), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain), ASTHENIA (lost of strenght, could not held a glass of water), FATIGUE (Fatigue), TOOTHACHE (Toothache) and CHILLS (chils). On 23-Jan-2021, CHILLS (chils) outcome was unknown. On 24-Jan-2021, PYREXIA (Really really high fever) outcome was unknown. At the time of the report, PAIN IN EXTREMITY (Arm pain), PAIN (Aches and pains), NAUSEA (Nausea), FEEDING DISORDER (Could not eat), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain), ASTHENIA (lost of strenght, could not held a glass of water), FATIGUE (Fatigue) and TOOTHACHE (Toothache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.